HCA Holdings Inc. diskutieren
HCA Holdings Inc.
WKN: A1JFMW / Symbol: HCA / Name: HCA Holdings / Aktie / Anbieter & Dienstleistungen / Large Cap /
404,40 €
-0,54 %
HCA Healthcare, Inc. (NYSE: HCA) had its price target raised by analysts at UBS Group AG from $405.00 to $438.00. They now have a "buy" rating on the stock.
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) had its price target raised by analysts at Truist Financial Co. from $390.00 to $430.00. They now have a "buy" rating on the stock.
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $392.00 price target on the stock.
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) had its price target raised by analysts at Royal Bank of Canada from $378.00 to $405.00. They now have an "outperform" rating on the stock.
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $392.00 price target on the stock.
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) is now covered by analysts at KeyCorp. They set an "overweight" rating and a $475.00 price target on the stock.
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) was upgraded by analysts at KeyCorp to a "strong-buy" rating.
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) had its price target raised by analysts at Oppenheimer Holdings Inc. from $390.00 to $400.00. They now have an "outperform" rating on the stock.
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) had its price target lowered by analysts at KeyCorp from $475.00 to $420.00. They now have an "overweight" rating on the stock.
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) had its price target lowered by analysts at TD Cowen from $450.00 to $440.00. They now have a "buy" rating on the stock.
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) had its price target lowered by analysts at Barclays PLC from $396.00 to $392.00. They now have an "overweight" rating on the stock.
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) was downgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "underweight" rating. They now have a $320.00 price target on the stock, down previously from $400.00.
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) had its price target lowered by analysts at Truist Financial Co. from $430.00 to $390.00. They now have a "buy" rating on the stock.
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) had its price target lowered by analysts at KeyCorp from $420.00 to $370.00. They now have an "overweight" rating on the stock.
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $405.00 price target on the stock.
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) had its price target lowered by analysts at Barclays PLC from $392.00 to $366.00. They now have an "overweight" rating on the stock.
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) had its price target lowered by analysts at Bank of America Co. from $380.00 to $370.00. They now have a "buy" rating on the stock.
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) had its price target lowered by analysts at Royal Bank of Canada from $405.00 to $384.00. They now have an "outperform" rating on the stock.
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) had its price target lowered by analysts at Royal Bank of Canada from $384.00 to $376.00. They now have an "outperform" rating on the stock.
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) had its price target raised by analysts at Barclays PLC from $366.00 to $416.00. They now have an "overweight" rating on the stock.
Ratings data for HCA provided by MarketBeat
Neueste Beiträge
Royal_Bank_of_Canada in EOG Resources Inc. diskutieren